FMS Fresenius Medical Care Corporation
Company Analysis
Latest News
Fresenius Medical Care Surges 7% on a New ICU Kidney Device — But Can One Product Shift a $10 Billion Company's Trajectory?
Shares of Fresenius Medical Care (NYSE: FMS) spiked +7.25% to $23.83 on October 22, defying a weak broader market, after the company's newly FDA-cleared...
🟢 Fresenius Medical Care jumps 7.25% after U.S. launch of multiFiltratePRO system
Fresenius Medical Care is trading at $23.83, up +7.25%, after hours. - The increase follows the U.S. launch of its multiFiltratePRO system, the first...
🔴 Fresenius Medical Care is trading 4.3% down
Fresenius Medical Care is trading at $21.00, down 4.31%; no confirmed company announcement explains the October 20 U.S. decline. - Its latest announced item...
🔴 Fresenius Medical Care is trading 5.8% down today amid macro-driven market pressure
Fresenius Medical Care is trading at $21.12 (-5.80%), with the decline appearing aligned with the wider macro-driven pullback rather than a confirmed company...
🔴 Fresenius Medical Care is trading at 4.7% down in after-hours trading — catalyst remains unclear
Fresenius Medical Care is trading 4.7% down at $21.38 in after-hours trading, with no clear company-specific catalyst identified. - The stock closed at $22.43...
🔴 Fresenius Medical Care is trading 5% down in after-hours trading; catalyst remains unclear
Fresenius Medical Care is trading at $21.51 (-5.03%) after hours; the catalyst is unclear. - On October 5, the after-hours move followed a regular-session...
Fresenius Medical Care Exits China Peritoneal Dialysis, Targets Innovation
Fresenius Medical Care is refining its commercial strategy in China to support long-term growth and strengthen its market position. The company plans to tailor...
Fresenius Medical Care Faces FDA Warning, Overlooked Leaking Dialysis Bag Risks
Fresenius Medical Care is responding to a U.S. Food and Drug Administration (FDA) warning letter following a March 2026 inspection. The inspection targeted the...
Fresenius Medical Care reports 28% lower mortality risk with HDF treatment
Fresenius Medical Care announced a multinational study published in the Journal of the American Society of Nephrology. High-volume hemodiafiltration (HDF)...